Ledger.Open graph →

SEC Form D · Amendment · filed June 16, 2022

Concerto Biosciences, Inc

Offering

$24.5M

Sold

$24.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

ALLSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Vera Schroeder · Allston, MADirector Bernardo Cervantes · Allston, MAExec · Director Cheri Ackerman · Allston, MAExec · Director Jared Kehe · Allston, MAExec · Director Caroline A. Feeney · Newark, NJDirector Susan G. Johnson · Newark, NJExec · Director Tom A. Kolinski · Boston, MAExec · Director Salene C. Hitchcock-Gear · Newark, NJExec · Director Sarah Luppino · Allston, MADirector Ed Anderson · Downers Grove, ILExec · Director Andrea Mancino · New York, NYExec · Director Justin Pateman · New York, NYExec · Director Sadie Mckeown · New York, NYDirector Sarah Luppino · Allston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗